New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

‘Smart’ Red Blood Cells Could Improve COVID-19 Vaccines

Scientists in Canada modified red blood cells with spike proteins to initiate an immune response against coronaviruses.

A recent Medgadget article discussed the development of a new method for protecting against COVID-19. A team of researchers at McMaster University modified red blood cells in hopes of protecting against future variants. The strategy involves repurposing red blood cells by emptying them out and attaching spike proteins, that mimic a coronavirus, to the outside. The method triggers the immune response without the use of genetic material, which essentially reduces side effects. A video with more information can be seen here.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub